CSI Market
Sign In | Register

Harvard Apparatus Regenerative Technology Inc (BSTG) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access BSTG Annual Cash Flow →
This cash flow overview for Harvard Apparatus Regenerative Technology Inc spans from Mar 31 2025 to Mar 31 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-1.60
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.63
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Amortization Of Right Of Use Assets-
Increase Decrease In Grant Receivables-
Increase Decrease In Deferred Financing Costs-
Finance Lease Right Of Use Asset Amortization-
Operating Lease Right Of Use Asset Amortization Expense0.03
Increase Decrease In Prepaid Research And Development-
Increase Decrease In Prepaid Long Term Contracts-0.11
Dividends Preferred Stock-
Conversion Of Stock Amount Converted-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Notes Issued-
Increase Decrease In Accrued And Other Current Liabilities0.31
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Accounts Payable-0.28
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.02
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.06
Discontinued operations0.00
Net Cash flow from Operating Activities-0.94
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale of Short-term Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Investment Made By Parent Company-
Proceeds From Issuance Of Series D Convertible Preferred Stock Common Stock And Warrants Net-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-0.94
Total Cash Flow-0.93
4 historic quarters locked

Sign in to unlock the full Harvard Apparatus Regenerative Technology Inc cash flow history.

Sign In Create Free Account

About Harvard Apparatus Regenerative Technology Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-26-027566

Figures are derived from filed reports and may be restated. Historical data is subject to revision.